Strategic Oncology Account Lead

Ipsen Colombia S.A.S; Bogotá; Presencial; COP 120.000.000 - 180.000.000; Jornada completa

Descripción de la vacante

Ipsen Colombia S.A.S in Bogota seeks an Account Lead SC to manage private and public market accounts in Colombia, delivering clinical and economic evidence and playing a key role in product launches. You will coordinate the account team, acting as the voice of the customer and driving proactive actions.

Develop account plans from brand strategy, execute tactics, ensure product availability, and promote clinical evidence in public institutions, while expanding private market opportunities and

Formación

• Education in business or HCP background.
• Experience in oncology therapeutics is desirable.
• Account leadership and management experience.
• Participation in product launches.
• Ability to translate opportunities and barriers into action.

Responsabilidades

• Coordinates the account team, acting as voice of the customer and proactive in course of action.
• Develops account plans based on brand strategy and executes tactics from segment opportunities.
• Executes account plans by identifying, analyzing, and engaging with stakeholders.
• Ensures product availability by managing sell-in, sell-out, inventories, and related metrics.
• Delivers clinical and economical evidence tailored to customer needs and supports product launches.
• Develops new markets and accounts in private and public institutions.

Conocimientos

Sales & negotiation techniques

Spanish

Communications capabilities

Digital adaptability

Educación

Business background

Life science degree

Descripción del empleo

Ipsen Colombia S.A.S in Bogota seeks an Account Lead SC to manage private and public market accounts in Colombia, delivering clinical and economic evidence and playing a key role in product launches. You will coordinate the account team, acting as the voice of the customer and driving proactive actions.

Develop account plans from brand strategy, execute tactics, ensure product availability, and promote clinical evidence in public institutions, while expanding private market opportunities and